[1]
V. De Sanctis, A. T. Soliman, S. Daar, and S. Di Maio, “Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men”, Acta Bio Med, vol. 90, no. 2, pp. 228-232, May 2019.